.jpg/fit-in/500x500/filters:no_upscale())
Demetri Maxim
CEO
Nephrogen
Demetri is the Founder and CEO of Nephrogen and has been actively immersed in kidney disease research since he was 14 years old. He completed his undergraduate and graduate research training at Stanford University in the Division of Nephrology under the mentorship of Vivek Bhalla, Avnesh Thakor, and renowned virologist, Mark Kay. Demetri also served as a Visiting Scientist in Dr. George Church’s lab at Harvard Medical School. Nephrogen’s underlying platform technology for discovering novel AAV delivery vehicles originated from work in the laboratories of Drs. George Church and Mark Kay.
Sessions
-
24-Jun-20265BNephrogen
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}